The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total debt is $64.61 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $64.61 B | 65.91% |
2022-12-31 | $38.94 B | 16.92% |
2021-12-31 | $33.30 B | 0.98% |
2020-12-31 | $32.98 B | 10.31% |
2019-12-31 | $29.90 B | -11.87% |
2018-12-31 | $33.92 B | -4% |
2017-12-31 | $35.34 B | 2.16% |
2016-12-31 | $34.59 B | 10.08% |
2015-12-31 | $31.42 B | 2.32% |
2014-12-31 | $30.71 B | -4.4% |
2013-12-31 | $32.12 B | 21.11% |
2012-12-31 | $26.52 B | 23.81% |
2011-12-31 | $21.42 B | 60.37% |
2010-12-31 | $13.36 B | 26.04% |
2009-12-31 | $10.60 B | 4.18% |
2008-12-31 | $10.17 B | -8.96% |
2007-12-31 | $11.17 B | 24.02% |
2006-12-31 | $9.01 B | 127.75% |
2005-12-31 | $3.95 B | -22.56% |
2004-12-31 | $5.11 B | 65.91% |
2003-12-31 | $3.08 B | -2.87% |
2002-12-31 | $3.17 B | 882.04% |
2001-12-31 | $0.32 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $33.63 B | -47.95% | ๐บ๐ธ USA |
Pfizer PFE | $70.84 B | 9.65% | ๐บ๐ธ USA |
AbbVie ABBV | $59.38 B | -8.09% | ๐บ๐ธ USA |
Eli Lilly LLY | $26.21 B | -59.43% | ๐บ๐ธ USA |
Biogen BIIB | $6.94 B | -89.25% | ๐บ๐ธ USA |
Gilead Sciences GILD | $24.98 B | -61.33% | ๐บ๐ธ USA |
Illumina ILMN | $2.26 B | -96.50% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $57.40 B | -11.15% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $22.45 B | -65.24% | ๐ฌ๐ง UK |